| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2118510 | Cancer/Radiothérapie | 2006 | 7 Pages |
Abstract
Between twenty and to forty percent of patients will develop an isolated PSA failure after a radical prostatectomy. Pelvic irradiation is a therapeutic option with curative intention. It is the best therapeutic option for young people with good prognostic factors. Combined radiation with hormonal or chemotherapy should be evaluated in patients with poor prognostic factors. For patients with a short life expectancy, hormonotherapy or a watch and see policy are acceptable options.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M. Bosset, J.-F. Bosset, P. Maingon,